Skip to main content
CTOR logo

CTOR · Citius Oncology, Inc. · Executive Compensation

Track CTOR — free
$0.87 +0.02 (+2.61%)
Market Cap
$94.92M
Shares
92.98M
Volume · Oct 7 21.19K Avg daily vol (3M) 98.03K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Jonathan Peri Appointed 2026-08-12
Brian Hartzband Resigned 2024-08-16
Taylor Zhang Resigned 2024-08-16
Taylor Zhang Resigned 2024-08-16
Cathy Jiang Resigned 2024-08-16
Myron Holubiak Appointed 2024-08-16
Xiaofeng Yuan Resigned 2024-08-16
Xiaofeng Yuan Resigned 2024-08-16
Leonard Mazur Appointed 2024-08-16
Leonard Mazur Appointed 2024-08-16
Dennis McGrath Appointed 2024-08-16
Suren Dutia Appointed 2024-08-16
Robert Smith Appointed 2024-08-16
Carol Webb Appointed 2024-08-16
Eugene Holuka Appointed 2024-08-16
Joel Mayersohn Appointed 2024-08-16
Myron Holubiak Appointed 2024-08-16
Leonard Mazur Appointed 2024-08-05
Dennis McGrath Appointed 2024-08-05
Suren Dutia Appointed 2024-08-05
Carol Webb Appointed 2024-08-05
Robert Smith Appointed 2024-08-05
Dr. Eugene Holuka Appointed 2024-08-05
Joel Mayersohn Appointed 2024-08-05
Myron Holubiak Appointed 2024-08-05
Key facts CIK 1851484 CUSIP 17331Y109 13F (30d) 1 filings 1 filers Visit website